High mobility group nucleosomal binding domain 2 pseudogene 32 (HMGN2P32)

High mobility group nucleosomal binding domain 2 pseudogene 32 (HMGN2P32) is an annotated pseudogene in the human genome[1][3][7]. Pseudogenes are DNA sequences that closely resemble functional genes but are generally incapable of producing functional proteins due to mutations or truncations[4][6]. While some pseudogenes can act as regulators of gene expression by serving as decoys for microRNAs or through generation of regulatory RNAs, there is no evidence that HMGN2P32 encodes a functional protein nor is it a therapeutic target[1][3][4][7]. As such, it should not be regarded as a receptor, enzyme, transporter, or any conventional therapeutic target category. Its nomenclature reflects homology to "high mobility group nucleosomal binding domain 2" genes but adds the pseudogene numbering convention according to gene annotation standards[4]. Note: This entry is not a therapeutic target, nor is it a functional gene or protein. There is no indication that this pseudogene has established importance in pharmacology, diagnostics, or disease beyond its annotation as a pseudogene. The entry is therefore flagged as incorrect for use as a canonical target in drug discovery or biomarker applications[1][3][4][7].

Other names

HMGN2P32high mobility group nucleosomal binding domain 2 pseudogene 32